Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03828747
Recruitment Status : Active, not recruiting
First Posted : February 4, 2019
Last Update Posted : March 15, 2022
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : July 20, 2021
Estimated Study Completion Date : August 23, 2023